chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: BAD FLU SYMPTOMS; VOMITING; FEELING STRANGE/JUST WEIRD FEELINGS IN HANDS; FEELING ANXIOUS; FEELING A LITTLE HYPER; INSOMNIA; APPETITE CHANGE; BODY FEELS LIKE ITS STARTING  TO HEAT UP AGAIN; NERVOUS FEELING; ILL FEELING/FEELING SICKER; NAUSEA; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced bad flu symptoms. On APR-2021, the subject experienced vomiting. On APR-2021, the subject experienced feeling strange/just weird feelings in hands. On APR-2021, the subject experienced feeling anxious. On APR-2021, the subject experienced feeling a little hyper. On APR-2021, the subject experienced insomnia. On APR-2021, the subject experienced appetite change. On APR-2021, the subject experienced body feels like its starting to heat up again. On APR-2021, the subject experienced nervous feeling. On APR-2021, the subject experienced ill feeling/feeling sicker. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bad flu symptoms, vomiting, feeling strange/just weird feelings in hands, feeling anxious, feeling a little hyper, insomnia, appetite change, ill feeling/feeling sicker, nervous feeling, nausea, fever, and body feels like its starting to heat up again. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Joint swelling
Clinical narrative: SWELLING IN JOINTS OF HANDS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On an unspecified date, the subject experienced swelling in joints of hands. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of swelling in joints of hands was not reported. This report was non-serious.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Peripheral swelling
Clinical narrative: PRETTY SEVERE SORENESS OR PAIN; SWELLING ARM; This spontaneous report received from a patient concerned a 30 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included seasonal allergy, non alcohol user, and non smoker, and other pre-existing medical conditions included the patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced pretty severe soreness or pain. On 01-APR-2021, the subject experienced swelling arm. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pretty severe soreness or pain, and swelling arm. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event, Mydriasis
Clinical narrative: DILATED PUPILS; EVERY SIDE EFFECT LISTED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced dilated pupils, and every side effect listed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dilated pupils and every side effect listed was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Muscle spasms, Muscle tightness, Pain in extremity
Clinical narrative: LEGS CRAMPING FROM CALVES DOWN TO HAMSTRINGS, BILATERALLY BUT WORSE ON THE LEFT SIDE; MUSCLES TIGHT; SORE LEG; CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient did not have known allergies and no comorbidities and no breastfeeding. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 21-JUN-2021) dose was not reported, administered on 04-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced headache. On 05-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced legs cramping from calves down to hamstrings, bilaterally but worse on the left side. On 12-APR-2021, the subject experienced muscles tight. On 12-APR-2021, the subject experienced sore leg. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, headache, and fever on 05-APR-2021, had not recovered from legs cramping from calves down to hamstrings, bilaterally but worse on the left side, and sore leg, and the outcome of muscles tight was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: LEGS CRAMPING FROM CALVES DOWN TO HAMSTRINGS, BILATERALLY BUT WORSE ON THE LEFT SIDE; MUSCLES TIGHT; SORE LEG; CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient did not have known allergies and no comorbidities and no breastfeeding. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 21-JUN-2021) dose was not reported, administered on 04-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced headache. On 05-APR-2021, the subject experienced fever. On 12-APR-2021, the subject experienced legs cramping from calves down to hamstrings, bilaterally but worse on the left side. On 12-APR-2021, the subject experienced muscles tight. On 12-APR-2021, the subject experienced sore leg. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, headache, and fever on 05-APR-2021, had not recovered from legs cramping from calves down to hamstrings, bilaterally but worse on the left side, and sore leg, and the outcome of muscles tight was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hypersomnia, Pain
Clinical narrative: BODY ACHE/BODY PAINS; SLEEPING; SEVERE CHILLS; FATIGUE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced body ache/body pains. On APR-2021, the subject experienced sleeping. On APR-2021, the subject experienced severe chills. On APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache/body pains, sleeping, severe chills, and fatigue on APR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Parosmia
Clinical narrative: PHANTOM SMELLS OF CIGARETTE SMOKE; GIVES A HEADS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced phantom smells of cigarette smoke. On MAR-2021, the subject experienced gives a heads. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from phantom smells of cigarette smoke, and the outcome of gives a heads was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain, Pyrexia
Clinical narrative: POUNDING HEADACHES; NAUSEA; FEVER; BODY ACHES; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced body aches. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced pounding headaches. On 05-APR-2021, the subject experienced nausea. On 05-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pounding headaches, nausea, fever, chills, and body aches. This report was non-serious.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Dry mouth, Electrocardiogram, Fatigue, Headache
Clinical narrative: DRY MOUTH; TINGLING IN HANDS; HEADACHE; NAUSEA; INCREASED FATIGUE; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. The patient's past medical history included thyroidectomy, and concurrent conditions included breast carcinoma, and teeth problems. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 17-MAR-2021, the subject experienced dry mouth. On 17-MAR-2021, the subject experienced tingling in hands. On 17-MAR-2021, the subject experienced headache. On 17-MAR-2021, the subject experienced nausea. On 17-MAR-2021, the subject experienced increased fatigue. Laboratory data (dates unspecified) included: Chest X-ray (NR: not provided) normal (units unspecified), and electrocardiogram (NR: not provided) normal (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, nausea, tingling in hands, increased fatigue, and dry mouth. This report was non-serious.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Paraesthesia
Clinical narrative: DRY MOUTH; TINGLING IN HANDS; HEADACHE; NAUSEA; INCREASED FATIGUE; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. The patient's past medical history included thyroidectomy, and concurrent conditions included breast carcinoma, and teeth problems. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 16-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 17-MAR-2021, the subject experienced dry mouth. On 17-MAR-2021, the subject experienced tingling in hands. On 17-MAR-2021, the subject experienced headache. On 17-MAR-2021, the subject experienced nausea. On 17-MAR-2021, the subject experienced increased fatigue. Laboratory data (dates unspecified) included: Chest X-ray (NR: not provided) normal (units unspecified), and electrocardiogram (NR: not provided) normal (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, nausea, tingling in hands, increased fatigue, and dry mouth. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nasal discomfort
Clinical narrative: SORENESS IN RIGHT NOSTRIL; CHILLS; MINOR HEADACHES; This spontaneous report received from a patient concerned a 68 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced soreness in right nostril. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced minor headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the soreness in right nostril, minor headaches and chills was not reported. This report was non-serious.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Influenza like illness, Pallor, Sleep disorder
Clinical narrative: PALE; WEAK; COULDN'T SLEEP; FLU-LIKE SYMPTOMS/HEADACHE/FATIGUE/LOST APPETITE/GENERALIZED BODY ACHES/SWEATING/DIZZINESS; This spontaneous report received from a patient concerned a 45 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthmatic, and low iron, and other pre-existing medical conditions included patient was not pregnant at the time of reporting.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced flu-like symptoms/headache/fatigue/lost appetite/generalized body aches/sweating/dizziness. On 10-APR-2021, the subject experienced couldn't sleep. On 11-APR-2021, the subject experienced weak. On 13-APR-2021, the subject experienced pale. Laboratory data included: Body temperature (NR: not provided) 97.1 F. Treatment medications (dates unspecified) included: paracetamol, loratadine, and diphenhydramine hydrochloride/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from weak, and flu-like symptoms/headache/fatigue/lost appetite/generalized body aches/sweating/dizziness, and the outcome of couldn't sleep and pale was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Pain
Clinical narrative: BODY PAIN FROM HER NECK TO ALL THE WAY  TO THE BACK OF HER SHOULDER ON THE LEFT SIDE OF HER BODY/SHOULDER; BODY PAIN FROM HER NECK TO ALL THE WAY  TO THE BACK OF HER SHOULDER ON THE LEFT SIDE OF HER BODY/SHOULDER; BODY PAIN FROM HER NECK TO ALL THE WAY  TO THE BACK OF HER SHOULDER ON THE LEFT SIDE OF HER BODY/SHOULDER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201AZIA expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced body pain from her neck to all the way to the back of her shoulder on the left side of her body/shoulder. On 09-APR-2021, the subject experienced body pain from her neck to all the way to the back of her shoulder on the left side of her body/shoulder. On 09-APR-2021, the subject experienced body pain from her neck to all the way to the back of her shoulder on the left side of her body/shoulder. Treatment medications (dates unspecified) included: menthol, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body pain from her neck to all the way to the back of her shoulder on the left side of her body/shoulder, body pain from her neck to all the way to the back of her shoulder on the left side of her body/shoulder, and body pain from her neck to all the way to the back of her shoulder on the left side of her body/shoulder. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Nonspecific reaction
Clinical narrative: LOT OF SYMPTOMS; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers No concomitant medications were reported. On an unspecified date, the subject experienced lot of symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of lot of symptoms was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain
Clinical narrative: INJECTION SITE TENDERNESS/SORENESS; INTERMITTENT HEADACHES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced injection site tenderness/soreness, and intermittent headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site tenderness/soreness, and intermittent headaches. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Breast discomfort, Burning sensation, Chest discomfort, Discomfort, Hypoaesthesia
Clinical narrative: PRESSURE IN THE CIRCLE AREA BETWEEN ARMPIT AND ABOVE THE BREAST (LEFT SIDE ONLY); BURNING AT ARMPIT AND ABOVE THE BREAST; NUMBNESS AT ARMPIT AND ABOVE THE BREAST; PRESSURE IN UPPER AREA ABOVE ARMPIT AREA; GETTING HEAVY ABOVE BREAST; HEAVY ARM; This spontaneous report received from a patient concerned a 36 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, abstains from alcohol, and non-smoker, and other pre-existing medical conditions included patient had no known allergies. no drug abuse/ illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-APR-2021, the subject experienced pressure in the circle area between armpit and above the breast (left side only). On 03-APR-2021, the subject experienced burning at armpit and above the breast. On 03-APR-2021, the subject experienced numbness at armpit and above the breast. On 03-APR-2021, the subject experienced pressure in upper area above armpit area. On 03-APR-2021, the subject experienced getting heavy above breast. On 03-APR-2021, the subject experienced heavy arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pressure in the circle area between armpit and above the breast (left side only), burning at armpit and above the breast, numbness at armpit and above the breast, pressure in upper area above armpit area, getting heavy above breast, and heavy arm. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: PRESSURE IN THE CIRCLE AREA BETWEEN ARMPIT AND ABOVE THE BREAST (LEFT SIDE ONLY); BURNING AT ARMPIT AND ABOVE THE BREAST; NUMBNESS AT ARMPIT AND ABOVE THE BREAST; PRESSURE IN UPPER AREA ABOVE ARMPIT AREA; GETTING HEAVY ABOVE BREAST; HEAVY ARM; This spontaneous report received from a patient concerned a 36 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, abstains from alcohol, and non-smoker, and other pre-existing medical conditions included patient had no known allergies. no drug abuse/ illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 03-APR-2021, the subject experienced pressure in the circle area between armpit and above the breast (left side only). On 03-APR-2021, the subject experienced burning at armpit and above the breast. On 03-APR-2021, the subject experienced numbness at armpit and above the breast. On 03-APR-2021, the subject experienced pressure in upper area above armpit area. On 03-APR-2021, the subject experienced getting heavy above breast. On 03-APR-2021, the subject experienced heavy arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pressure in the circle area between armpit and above the breast (left side only), burning at armpit and above the breast, numbness at armpit and above the breast, pressure in upper area above armpit area, getting heavy above breast, and heavy arm. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Pain, Paraesthesia
Clinical narrative: TINGLING; DIARRHEA; ACHES; This spontaneous report received from a patient concerned a 66 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included contrast dye allergy, and novocaine allergy, and other pre-existing medical conditions included patient is allergic to novocaine and contrast dye. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 180898L expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced tingling. On 07-APR-2021, the subject experienced diarrhea. On 07-APR-2021, the subject experienced aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tingling, diarrhea, and aches. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax, Diarrhoea, Erythema, Magnetic resonance imaging, Paraesthesia
Clinical narrative: TINGLING; DIARRHEA; ACHES; This spontaneous report received from a patient concerned a 66 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included contrast dye allergy, and novocaine allergy, and other pre-existing medical conditions included patient is allergic to novocaine and contrast dye. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 180898L expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced tingling. On 07-APR-2021, the subject experienced diarrhea. On 07-APR-2021, the subject experienced aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tingling, diarrhea, and aches. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache
Clinical narrative: ICKY; BAD HEADACHES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 2021, the subject experienced icky. On 2021, the subject experienced bad headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bad headaches, and was recovering from icky. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: SORE SPOTS/ SORE ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sore spots/ sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore spots/ sore arm was not reported. This report was non-serious.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site haemorrhage, Injection site pain, Underdose
Clinical narrative: BLOOD WENT OUT ABOUT 4 INCHES AT INJECTION SITE; POSSIBLE PARTIAL DOSE ADMINISTERED; PAIN AT THE INJECTION SITE (HURTS SO MUCH)/VERY BURNING SENSATION; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced blood went out about 4 inches at injection site. On 07-APR-2021, the subject experienced possible partial dose administered. On 07-APR-2021, the subject experienced pain at the injection site (hurts so much)/very burning sensation. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain at the injection site (hurts so much)/very burning sensation on APR-2021, and the outcome of possible partial dose administered and blood went out about 4 inches at injection site was not reported. This report was non-serious.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Chills, Headache, Hypertension
Clinical narrative: POUNDING HEADACHES; FEVER; HIGH BLOOD PRESSURE; CHILLS; This spontaneous report received from a patient concerned a 45 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and high blood pressure, and other pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 09:45 for prophylactic vaccination. Concomitant medications included amlodipine for high blood pressure. On 10-APR-2021, the subject experienced high blood pressure. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever.  Laboratory data included: Body temperature (NR: not provided) 101.5 F. On 10-APR-2021 14:00, the subject experienced pounding headaches. On 12-APR-2021, Laboratory data included: Blood pressure (NR: not provided) 159/110 mmHg. On 13-APR-2021, Laboratory data included: Blood pressure (NR: not provided) 148/102 mmHg, 112/78 mmHg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 10-APR-2021, and had not recovered from pounding headaches, and high blood pressure. This report was non-serious.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: POUNDING HEADACHES; FEVER; HIGH BLOOD PRESSURE; CHILLS; This spontaneous report received from a patient concerned a 45 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and high blood pressure, and other pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 09:45 for prophylactic vaccination. Concomitant medications included amlodipine for high blood pressure. On 10-APR-2021, the subject experienced high blood pressure. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever.  Laboratory data included: Body temperature (NR: not provided) 101.5 F. On 10-APR-2021 14:00, the subject experienced pounding headaches. On 12-APR-2021, Laboratory data included: Blood pressure (NR: not provided) 159/110 mmHg. On 13-APR-2021, Laboratory data included: Blood pressure (NR: not provided) 148/102 mmHg, 112/78 mmHg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 10-APR-2021, and had not recovered from pounding headaches, and high blood pressure. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: CHILLS; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The Company is unable to perform follow-up to request batch/lot number.  No concomitant medications were reported. On an unspecified date, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of chills was not reported. This report was non-serious.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dry mouth, Feeling abnormal, Headache
Clinical narrative: FEELING BAD; BODY WAS HURTING; LOSS OF ENERGY; HEADACHE; GETTING A COLD; DRY MOUTH; DIARRHEA; This spontaneous report received from a patient concerned a 51 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 and  expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 2021, the subject experienced dry mouth. On 2021, the subject experienced diarrhea. On 2021, the subject experienced body was hurting. On 2021, the subject experienced loss of energy. On 2021, the subject experienced headache. On 2021, the subject experienced getting a cold. On 10-APR-2021, the subject experienced feeling bad. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dry mouth, and feeling bad, and the outcome of diarrhea, body was hurting, headache, loss of energy and getting a cold was not reported. This report was non-serious.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain
Clinical narrative: FEELING BAD; BODY WAS HURTING; LOSS OF ENERGY; HEADACHE; GETTING A COLD; DRY MOUTH; DIARRHEA; This spontaneous report received from a patient concerned a 51 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018 and  expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 2021, the subject experienced dry mouth. On 2021, the subject experienced diarrhea. On 2021, the subject experienced body was hurting. On 2021, the subject experienced loss of energy. On 2021, the subject experienced headache. On 2021, the subject experienced getting a cold. On 10-APR-2021, the subject experienced feeling bad. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dry mouth, and feeling bad, and the outcome of diarrhea, body was hurting, headache, loss of energy and getting a cold was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Disorientation, Fatigue, Gastrointestinal disorder, Headache
Clinical narrative: THROBBING FEELING IN THE LEGS; DIARRHEA; VOMITING; LYMPH NODE PAIN (RIGHT SIDE OF THE NECK); DISORIENTED; FEVER; MUSCLE ACHE; FATIGUE; NAUSEA; HEADACHE; INJECTION SITE PAIN; LYMPH NODE SWELLING (RIGHT SIDE); GASTROINTESTINAL ISSUES; This spontaneous report received from a patient concerned a 44 year old female. The patient's weight was 195 pounds, and height was 160 centimeters. The patient's past medical history included antiphospholipid syndrome, and irritable bowel syndrome, and concurrent conditions included azithromycin allergy, clarithromycin allergy, and alcoholic, and other pre-existing medical conditions included the patient is allergic and intolerant to macrolide antibiotics (azithromycin and clarithromycin) patient is alcoholic and consumes alcohol occasionally or once a week patient does not smoke. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication. On 08-APR-2021, the subject experienced lymph node swelling (right side). On 08-APR-2021, the subject experienced gastrointestinal issues. On 08-APR-2021, the subject experienced lymph node pain (right side of the neck). On 08-APR-2021, the subject experienced disoriented. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced muscle ache. On 08-APR-2021, the subject experienced fatigue. On 08-APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced injection site pain. On 09-APR-2021, the subject experienced diarrhea. On 09-APR-2021, the subject experienced vomiting. On 12-APR-2021, the subject experienced throbbing feeling in the legs. Treatment medications (dates unspecified) included: diphenhydramine citrate/ibuprofen, and oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea on 10-APR-2021, fever, muscle ache, and fatigue on 09-APR-2021, and injection site pain on 11-APR-2021, had not recovered from nausea, and the outcome of headache, vomiting, throbbing feeling in the legs, lymph node swelling (right side), gastrointestinal issues, lymph node pain (right side of the neck) and disoriented was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Lymph node pain, Lymphadenopathy, Myalgia, Nausea
Clinical narrative: THROBBING FEELING IN THE LEGS; DIARRHEA; VOMITING; LYMPH NODE PAIN (RIGHT SIDE OF THE NECK); DISORIENTED; FEVER; MUSCLE ACHE; FATIGUE; NAUSEA; HEADACHE; INJECTION SITE PAIN; LYMPH NODE SWELLING (RIGHT SIDE); GASTROINTESTINAL ISSUES; This spontaneous report received from a patient concerned a 44 year old female. The patient's weight was 195 pounds, and height was 160 centimeters. The patient's past medical history included antiphospholipid syndrome, and irritable bowel syndrome, and concurrent conditions included azithromycin allergy, clarithromycin allergy, and alcoholic, and other pre-existing medical conditions included the patient is allergic and intolerant to macrolide antibiotics (azithromycin and clarithromycin) patient is alcoholic and consumes alcohol occasionally or once a week patient does not smoke. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication. On 08-APR-2021, the subject experienced lymph node swelling (right side). On 08-APR-2021, the subject experienced gastrointestinal issues. On 08-APR-2021, the subject experienced lymph node pain (right side of the neck). On 08-APR-2021, the subject experienced disoriented. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced muscle ache. On 08-APR-2021, the subject experienced fatigue. On 08-APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced injection site pain. On 09-APR-2021, the subject experienced diarrhea. On 09-APR-2021, the subject experienced vomiting. On 12-APR-2021, the subject experienced throbbing feeling in the legs. Treatment medications (dates unspecified) included: diphenhydramine citrate/ibuprofen, and oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea on 10-APR-2021, fever, muscle ache, and fatigue on 09-APR-2021, and injection site pain on 11-APR-2021, had not recovered from nausea, and the outcome of headache, vomiting, throbbing feeling in the legs, lymph node swelling (right side), gastrointestinal issues, lymph node pain (right side of the neck) and disoriented was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Vomiting
Clinical narrative: THROBBING FEELING IN THE LEGS; DIARRHEA; VOMITING; LYMPH NODE PAIN (RIGHT SIDE OF THE NECK); DISORIENTED; FEVER; MUSCLE ACHE; FATIGUE; NAUSEA; HEADACHE; INJECTION SITE PAIN; LYMPH NODE SWELLING (RIGHT SIDE); GASTROINTESTINAL ISSUES; This spontaneous report received from a patient concerned a 44 year old female. The patient's weight was 195 pounds, and height was 160 centimeters. The patient's past medical history included antiphospholipid syndrome, and irritable bowel syndrome, and concurrent conditions included azithromycin allergy, clarithromycin allergy, and alcoholic, and other pre-existing medical conditions included the patient is allergic and intolerant to macrolide antibiotics (azithromycin and clarithromycin) patient is alcoholic and consumes alcohol occasionally or once a week patient does not smoke. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication. On 08-APR-2021, the subject experienced lymph node swelling (right side). On 08-APR-2021, the subject experienced gastrointestinal issues. On 08-APR-2021, the subject experienced lymph node pain (right side of the neck). On 08-APR-2021, the subject experienced disoriented. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced muscle ache. On 08-APR-2021, the subject experienced fatigue. On 08-APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced injection site pain. On 09-APR-2021, the subject experienced diarrhea. On 09-APR-2021, the subject experienced vomiting. On 12-APR-2021, the subject experienced throbbing feeling in the legs. Treatment medications (dates unspecified) included: diphenhydramine citrate/ibuprofen, and oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea on 10-APR-2021, fever, muscle ache, and fatigue on 09-APR-2021, and injection site pain on 11-APR-2021, had not recovered from nausea, and the outcome of headache, vomiting, throbbing feeling in the legs, lymph node swelling (right side), gastrointestinal issues, lymph node pain (right side of the neck) and disoriented was not reported. This report was non-serious.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Nausea, Pyrexia
Clinical narrative: CHILLS; FEVER; NAUSEA; FATIGUE; This spontaneous report received from a patient via a company representative concerned a 22 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 03-APR-2021, the subject experienced chills. On 03-APR-2021, the subject experienced fever. On 03-APR-2021, the subject experienced nausea. On 03-APR-2021, the subject experienced fatigue. Laboratory data included: Body temperature (NR: not provided) 101.8 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, nausea and fatigue was not reported. This report was non-serious.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Dizziness, Feeling abnormal, Headache
Clinical narrative: DIZZINESS; BODY ACHE; CHILLS; HEADACHE; FEVER; PAIN RADIATED TO THE BACK; STINGING SENSATION; FELT TERRIBLE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029,  expiry: 25-MAY-2021) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination.  No concomitant medications were reported. On 17-MAR-2021, the subject experienced stinging sensation. On 17-MAR-2021, the subject experienced felt terrible. On 17-MAR-2021, the subject experienced pain radiated to the back. On 18-MAR-2021, the subject experienced dizziness. On 18-MAR-2021, the subject experienced body ache. On 18-MAR-2021, the subject experienced chills. On 18-MAR-2021, the subject experienced headache. On 18-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stinging sensation on 23-MAR-2021, and felt terrible, dizziness, body ache, pain radiated to the back, chills, headache, and fever. This report was non-serious.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: DIZZINESS; BODY ACHE; CHILLS; HEADACHE; FEVER; PAIN RADIATED TO THE BACK; STINGING SENSATION; FELT TERRIBLE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029,  expiry: 25-MAY-2021) dose was not reported, administered on 17-MAR-2021 for prophylactic vaccination.  No concomitant medications were reported. On 17-MAR-2021, the subject experienced stinging sensation. On 17-MAR-2021, the subject experienced felt terrible. On 17-MAR-2021, the subject experienced pain radiated to the back. On 18-MAR-2021, the subject experienced dizziness. On 18-MAR-2021, the subject experienced body ache. On 18-MAR-2021, the subject experienced chills. On 18-MAR-2021, the subject experienced headache. On 18-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stinging sensation on 23-MAR-2021, and felt terrible, dizziness, body ache, pain radiated to the back, chills, headache, and fever. This report was non-serious.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain in extremity
Clinical narrative: SORE LEGS; NOT FEELING WELL; This spontaneous report received from a patient via a company representative concerned a 37 year old petit female. The patient's height, and weight were not reported. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sore legs, and not feeling well. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore legs and not feeling well was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Pyrexia
Clinical narrative: FEVER; FATIGUE; EXTREME JOINT PAIN IN ARMS AND HANDS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included neuroendocrine tumor. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  Concomitant medications included octreotide acetate for neuroendocrine tumor. On APR-2021, the subject experienced extreme joint pain in arms and hands. On APR-2021, the subject experienced fatigue. On 02-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.8 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, fatigue and extreme joint pain in arms and hands was not reported. This report was non-serious.